MADRIGAL PHARMACEUTICALS

madrigal-pharmaceuticals-logo

Madrigal Pharmaceuticals is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The Company is targeting treatment of both niche and prevalent indications, including diabetes, dyslipidemia and cardiovascular disease.

#People #Financial #Event #Website #More

MADRIGAL PHARMACEUTICALS

Industry:
Biotechnology Medical Device Pharmaceutical

Founded:
2011-01-01

Address:
Washington, Pennsylvania, United States

Country:
United States

Website Url:
http://www.madrigalpharma.com

Total Employee:
1+

Status:
Active

Contact:
(267) 327-4445

Email Addresses:
[email protected]

Total Funding:
288.38 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Nginx IPv6



Current Advisors List

fred-craves_image

Fred Craves Board Member @ Madrigal Pharmaceuticals
Board_member

Current Employees Featured

rebecca-taub_image

Rebecca Taub
Rebecca Taub Founder, Director and CMO, President R&D at Madrigal Pharmaceuticals @ Madrigal Pharmaceuticals
Founder, Director and CMO, President R&D at Madrigal Pharmaceuticals
2016-07-01

dominic-f-labriola_image

Dominic F. Labriola
Dominic F. Labriola Chief Data and Analytics Officer @ Madrigal Pharmaceuticals
Chief Data and Analytics Officer
2022-01-01

rebecca-taub_image

Rebecca Taub
Rebecca Taub CEO @ Madrigal Pharmaceuticals
CEO
2011-09-01

Founder


rebecca-taub_image

Rebecca Taub

Stock Details


Company's stock symbol is NASDAQ:MDGL

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Madrigal Pharmaceuticals

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Post-IPO Equity - Madrigal Pharmaceuticals

Official Site Inspections

http://www.madrigalpharma.com Semrush global rank: 2.78 M Semrush visits lastest month: 5.83 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Madrigal Pharmaceuticals"

Home - Madrigal

Jul 22, 2025 Delivering a Breakthrough Treatment Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis …See details»

Madrigal Pharmaceuticals Org Chart + Executive Team

The org chart of Madrigal Pharmaceuticals contains its 32 main executives like Bill Sibold, Mardi Dier and Mark Barrett.See details»

Madrigal Pharmaceuticals (MDGL) Company Profile & Description

2 days ago Company profile for Madrigal Pharmaceuticals, Inc. (MDGL) stock, with a description, list of executives, contact details and other key facts.See details»

Madrigal Pharmaceuticals - Crunchbase Company …

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.See details»

Madrigal Medical Affairs – A clinical-stage …

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction steatohepatitis (MASH/NASH).See details»

About Madrigal - Madrigal

About Madrigal A madrigal is a form of Renaissance choral music known for beautiful harmonies. At Madrigal Pharmaceuticals, our work focuses on restoring balance and harmony to the liver, …See details»

Madrigal Pharmaceuticals Inc - Company Profile - GlobalData

Madrigal Pharmaceuticals Inc (Madrigal) is a biopharmaceutical company that focuses on developing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as …See details»

Our Leaders - Madrigal

Working at Madrigal Interested in making a difference in the lives of people living with MASH? Join our talented, diverse and dedicated team.See details»

Madrigal Pharmaceuticals (LON:0JXI) Company Profile & Description

Jul 22, 2025 Company profile for Madrigal Pharmaceuticals, Inc. (LON:0JXI) with a description, list of executives, contact details and other key facts.See details»

Madrigal Pharmaceuticals Announces Leadership Transition

Apr 16, 2025 Madrigal Pharmaceuticals announces management changes, with Rebecca Taub transitioning to Senior Scientific Advisor and David Soergel as Chief Medical Officer.See details»

Madrigal Pharmaceuticals Appoints Bill Sibold as Chief

Sep 11, 2023 From 2017 until joining Madrigal, Mr. Sibold served as Executive Vice President, Specialty Care of Sanofi and President, Sanofi North America, where he led a global …See details»

Overview | Madrigal Pharmaceuticals, Inc.

Jul 16, 2025 The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»

Madrigal Pharmaceuticals Enters into Exclusive Global License …

1 day ago The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»

Community - Madrigal

The Fatty Liver Foundation is the only national, non-profit, patient organization dedicated to improving the identification, diagnosis, treatment and support of Americans with fatty liver, …See details»

Corporate Governance | Madrigal Pharmaceuticals, Inc.

The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»

Our Medicine - Madrigal

For Patients Patient Information For Healthcare Professionals Prescribing Information For U.S. audiences only Madrigal Patient Support Support for patients along every step of their journey, …See details»

Press Releases | Madrigal Pharmaceuticals, Inc.

May 1, 2025 Find the latest press releases and updates from Madrigal Pharmaceuticals, a biopharmaceutical company focused on liver-directed therapies for serious liver diseases.See details»

Financials and Filings | Madrigal Pharmaceuticals, Inc.

Feb 25, 2021 The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»

Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial …

Mar 31, 2025 Madrigal Pharmaceuticals shares first-quarter 2025 financial results and updates on its progress in developing novel therapeutics for liver diseases.See details»

Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial …

Sep 30, 2024 The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»

linkstock.net © 2022. All rights reserved